Skip to main content

Table 3 Recorded dietary intake at baseline (week 0) and following diets that incorporated the control and modified dairy products (week 12) in adults at moderate cardiovascular disease risk and target fatty acid intakesa

From: Plasma phospholipid fatty acid profile confirms compliance to a novel saturated fat-reduced, monounsaturated fat-enriched dairy product intervention in adults at moderate cardiovascular risk: a randomized controlled trial

  Control Modified
Baseline Post Tb Δ Baseline Post T Δ p c
Energy, MJ/d 8.5 ± 0.4 9.0 ± 0.3   0.5 ± 0.3 8.2 ± 0.3 9.2 ± 0.4   1.0 ± 0.4 0.60
Total fat, %TE 36.5 ± 0.8 39.5 ± 0.7 38.0 3.0 ± 0.9 36.1 ± 0.8 41.1 ± 0.8 38.0 5.0 ± 1.1 0.03
SFA, %TE 13.9 ± 0.5 19.1 ± 0.4 19.0 5.2 ± 0.6 14.2 ± 0.5 16.9 ± 0.4 16.0 2.7 ± 0.6 <0.001
MUFA, %TE 11.9 ± 0.4 11.8 ± 0.3 11.0 −0.1 ± 0.3 11.7 ± 0.4 15.3 ± 0.4 14.0 3.6 ± 0.5 <0.0001
n-6 PUFA, %TE 4.6 ± 0.2 3.3 ± 0.2   −1.3 ± 0.2 3.9 ± 0.2 3.4 ± 0.2   −0.5 ± 0.2 0.08
n-3 PUFA, %TE 0.8 ± 0.1 0.6 ± 0.0   −0.2 ± 0.1 0.7 ± 0.0 0.6 ± 0.0   −0.1 ± 0.1 0.34
Total PUFA, %TE 5.8 ± 0.4 4.4 ± 0.5   −1.4 ± 0.3 4.6 ± 0.2 4.0 ± 0.2   −0.4 ± 0.2 0.14
TFA, %TE 1.0 ± 0.1 1.3 ± 0.1   0.3 ± 0.1 0.9 ± 0.1 2.5 ± 0.1   1.6 ± 0.1 <0.0001
Protein, %TE 16.3 ± 0.5 16.1 ± 0.4   −0.2 ± 0.5 16.9 ± 0.5 16.2 ± 0.3   −0.7 ± 0.6 0.80
Carbohydrates, %TE 46.3 ± 0.9 43.3 ± 0.9   −3.0 ± 0.9 46.6 ± 1.3 42.2 ± 1.0   −4.4 ± 1.5 0.19
Alcohol, %TE 3.1 ± 0.5 3.1 ± 0.5   0.0 ± 0.4 2.9 ± 0.5 2.7 ± 0.4   −0.2 ± 0.5 0.35
Dietary fiber (AOAC), g/d 20.4 ± 1.1 22.0 ± 1.1   1.6 ± 0.9 20.2 ± 1.1 19.4 ± 1.1   −0.8 ± 1.2 0.03
Sodium, g/d 2.7 ± 0.2 2.2 ± 0.1   −0.5 ± 0.1 2.5 ± 0.2 1.9 ± 0.1   −0.6 ± 0.1 0.03
  1. Participant was included as a random effect. p ≤ 0.01 deemed as significant
  2. AOAC Association of Official Analytic Chemists, %TE percentage of total energy
  3. aValues are means ± SEM. Dietary intakes estimated from 4-d weighed dietary records at baseline (week 0) and after intervention (week 12)
  4. bTarget FA intakes for the control and modified dietary exchange periods
  5. cOverall effect of treatment based on change-from-baseline was calculated by mixed model analysis, with adjustments made for fixed effects of baseline values of the assessed variable, period, treatment, age, gender and BMI